Icon Reports Q2 Revenue Growth and Strong Bookings Amid Margin Pressures
Icon Plc (NASDAQ:ICLR) reported second-quarter 2026 revenue of $2.1 billion, a 1.2% year-over-year increase driven by higher pass-through activity. Adjusted EBITDA rose to $327.2 million and adjusted EPS reached $2.56. Management reaffirmed full-year guidance while noting that business-mix pressures continued to impact reported margins, which fell to 15.9%. The company generated strong bookings with gross wins up 24% year-over-year to $3.7 billion and a net book-to-bill ratio of 1.51x. Icon's direct-fee bookings maintained solid performance with a 1.2x net book-to-bill ratio, reflecting broad-based customer demand across pharmaceutical and biotech sectors. CEO Barry Balfe highlighted disciplined cost management alongside strong demand as key drivers for the quarter. CFO Nigel Clerkin noted that pass-through activity had an outsized impact on revenue but weighed on margins. The company plans to resume share repurchases while investing in its China expansion and AI-enabled clinical-trial operations, signaling continued growth ambitions despite margin challenges.
Tickers: $ICLR
Topics: adjusted_ebitda bookings free_cash_flow revenue